reduced turnaround time, enables real-time trend analysis and decision-making for enhanced compliance and sanitation. These advanced assays, set to be available to trial customers in 2024, complement Ancera's existing diagnostic tools, forming part of the company's digital command center for poultry. “PIPER is the only platform that combines molecular and classical microbiology capabilities with an operationally relevant time-to-result. The Clostridium and TVB assays will double the number of novel assays on the PIPER platform,” said Arjun Ganesan, CEO of Ancera. “We are excited to share these assays with trial partners as we develop the data science models and software for full commercialisation.” The Clostridium assay allows integrators to monitor and enumerate C. perfringens, providing insights into bacterial load, production metrics, and overall animal health. When combined with Ancera’s Coccidia System Monitoring (CSM) product, it offers comprehensive visibility into the effects of gut health on production in near real-time. The TVB assay on the other hand, facilitates same-shift process improvement and quality control, enabling real-time trend analysis and decision- making for enhanced compliance and sanitation. These tools empower integrators and producers with rapid and reliable methods for detecting microbial presence across flocks, aiding in timely decision-making and ultimately enhancing productivity and food safety in the poultry industry. n POULTRY These tools empower integrators and producers with rapid and reliable microbial detection methods. Total Viable Bacteria. March/April 2024 | www.africanfarming.net 10 Image Credit: Ancera